Search results

76 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Biomedical engineer Zhen Gu, PhD, tabbed as top young innovator
The editors of the MIT Technology Review highlighted Gu’s work on a novel way to monitor and treat diabetes.
Located in News / 2015 / August
UNC’s Sue Kirkman, MD, co-authors first-ever ADA position paper on Type 1 diabetes
The newest American Diabetes Association treatment guidelines for the disease are in place at UNC Medical Center.
Located in News / 2014 / June
MUSC and UNC-Chapel Hill join forces to test a diabetes outreach program
The Bamberg Diabetes Transitional Care Study will utilize cutting-edge iPad technology to explore the impact and feasibility of different diabetes interventions for patients transitioning from the hospital to home.
Located in News / 2014 / August
Join our #T1Dchat on Twitter – Aug. 19 at 1 p.m. ET!
Participating in the chat will be two diabetes experts and co-authors of a new American Diabetes Association position statement on the care of people with type 1 diabetes.
Located in News / 2014 / August
Common diabetes drug not linked to short-term risk of pancreatic cancer
UNC researchers overturn a controversial study about DPP-4 inhibitors – commonly prescribed diabetes medications.
Located in News / 2014 / September
Diabetes researchers urge for new screening and management approach
By treating people earlier, doctors could help diabetes patients avoid the most severe, life-threatening complications that stem from prolonged periods of elevated blood glucose.
Located in News / 2014 / September
To test or not to test: Blood glucose monitoring for patients with type 2 diabetes
The Patient-Centered Outcomes Research Institute awards UNC School of Medicine researchers more than $2 million to study glucose monitoring in non-insulin treated patients living with type 2 diabetes.
Located in News / 2013 / May
UNC Diabetes Care Center begins recruitment for long-term study of diabetes drug efficacy
Beginning recruitment in June, the project is called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study. UNC will enroll patients at locations in Durham and Greensboro, N.C.
Located in News / 2013 / June
UNC begins clinical trial of EndoBarrier® for treatment of type 2 diabetes
The ENDO Trial is currently enrolling adults between the ages of 21 and 65 who have uncontrolled type 2 diabetes and are obese.
Located in News / 2013 / July
UNC and SAS join forces to personalize health care for better outcomes
Collaboration will leverage big data to help providers engage patients to manage diabetes, improve health
Located in News / 2013 / November